Ciba of Switzerland's eye care business, Ciba Vision, along with the Ciba-Geigy Foundation for Cooperation with Developing Countries, has announced a five-year program, valued at around 3.5 million Swiss francs ($3 million), to contribute significantly to training for eye care professionals in China and safeguard the optical health of Chinese contact lens wearers.
The company is also understood to be looking at making India a sourcing base for its global requirements, with plans for clinical research and the introduction of a new range of over-the-counter drugs.
Alex Krauer, chairman of Ciba, recently spent two days visiting the country for discussions on expansion of the business in India, according to local reports. Ciba's generic business, Geneva, may source its requirements in India, Mr Krauer is reported to have indicated.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze